MyFinsight
Home
Blog
About
Contact
Download
Download image
Financial royalty assets
$779,844K
(8.83%↑ Y/Y)
Cash and cash
equivalents
$586,395K
(-46.09%↓ Y/Y)
Other royalty income
receivable
$27,511K
(15.67%↑ Y/Y)
Available for sale debt
securities
$21,900K
(80.99%↑ Y/Y)
Other current assets
$10,161K
(230.01%↑ Y/Y)
Financial royalty assets,
net
$16,542,353K
(10.05%↑ Y/Y)
Total current assets
$1,425,811K
(-22.65%↓ Y/Y)
Goodwill
$924,634K
Available for sale debt
securities
$406,800K
(85.75%↑ Y/Y)
Equity method
investments
$265,697K
(-20.97%↓ Y/Y)
Equity securities
$173,270K
(22.81%↑ Y/Y)
Other assets
$76,850K
(109.36%↑ Y/Y)
Total assets
$19,815,415K
(12.53%↑ Y/Y)
Total liabilities and
shareholders equity
$19,815,415K
(12.53%↑ Y/Y)
Total shareholders
equity
$9,936,833K
(1.51%↑ Y/Y)
Total liabilities
$9,878,582K
(26.33%↑ Y/Y)
Treasury interests
$2,709K
(2.07%↑ Y/Y)
Additional paid-in capital
$4,384,056K
(4.12%↑ Y/Y)
Non-controlling interests
$3,048,287K
(-1.67%↓ Y/Y)
Retained earnings
$2,507,091K
(1.07%↑ Y/Y)
Long-term debt
$8,576,443K
(29.58%↑ Y/Y)
Accrued compensation
liabilities
$648,672K
Total current
liabilities
$535,682K
(-54.71%↓ Y/Y)
Other liabilities
$117,785K
(558.02%↑ Y/Y)
Common stock-Class
RRedeemable Stock
$63K
(0.00%↑ Y/Y)
Common stock-Common
Class A
$45K
(4.65%↑ Y/Y)
Current portion of
long-term debt
$380,000K
(138.05%↑ Y/Y)
Distributions payable to
non-controlling interests
$87,417K
(-19.65%↓ Y/Y)
Accounts payable and
accrued liabilities
$25,483K
(-32.28%↓ Y/Y)
Interest payable
$25,302K
(31.64%↑ Y/Y)
Other current
liabilities
$17,480K
(-6.02%↓ Y/Y)
Back
Back
Balance Sheet
source: myfinsight.com
1-svg
Royalty Pharma plc (RPRX)
1-svg
Royalty Pharma plc (RPRX)